Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 4228-4235

  Huhtinen, Kaisa ^a,b   Desai, Reena ^c   Stah̊le, Mia ^a   Salminen, Anu ^a   Handelsman, David J ^c   Perheentupa, Antti ^a,b   Poutanen, Matti ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; MESSENGER RNA; TESTOSTERONE 17BETA DEHYDROGENASE;

AKR1C3 GENE; ARTICLE; CONTROLLED STUDY; CYP19A1 GENE; DNA MICROARRAY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; GENE; GENE EXPRESSION; HSD17B1 GENE; HSD17B2 GENE; HSD17B6 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE LEVEL;

ADULT; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; ESTRONE; FEMALE; HUMANS; OVARIAN DISEASES; PERITONEAL DISEASES;

EID: 84868620900     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1154     Document Type: Article

References (33)

1. Aghajanova L, Hamilton A, Kwintkiewicz J, Vo KC, Giudice LC 2009 Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis. Biol Reprod 80:105-114
2. Giudice LC 2010 Clinical practice. Endometriosis. N Engl J Med 362:2389-2398
3. Huhtinen K, Ståhle M, Perheentupa A, Poutanen M 2012 Estrogen biosynthesis and signaling in endometriosis. Mol Cell Endocrinol 358:146-154
4. Delvoux B, Groothuis P, D'Hooghe T, Kyama C, Dunselman G, Romano A 2009 Increased production of 17β-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 94:876-883
5. Carlström K, Bergqvist A, Ljungberg O 1988 Metabolism of estrone sulfate in endometriotic tissue and in uterine endometrium. Fertil Steril 49:229-233
6. Purohit A, Fusi L, Brosens J, Woo LW, Potter BV, Reed MJ 2008 Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy. Hum Reprod 23:290-297 (Pubitemid 351651236)
7. Colette S, Defrère S, Lousse JC, Van Langendonckt A, Gotteland JP, Loumaye E, Donnez J 2011 Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model. Hum Reprod 26:1362-1370
8. Attar E, Tokunaga H, Imir G, Yilmaz MB, Redwine D, Putman M, Gurates B, Attar R, Yaegashi N, Hales DB, Bulun SE 2009 Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab 94:623-631
9. Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, Husen B, Thole H, Dunselman G, Groothuis P 2007 Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 22:3148-3158 (Pubitemid 351696776)
10. Noble LS, Simpson ER, Johns A, Bulun SE 1996 Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174-179 (Pubitemid 26035021)
11. Hudelist G, Czerwenka K, Keckstein J, Haas C, Fink-Retter A, Gschwantler-Kaulich D, Kubista E, Singer CF 2007 Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci 14:798-805 (Pubitemid 351903565)
12. Bukulmez O, Hardy DB, Carr BR, Word RA, Mendelson CR 2008 Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 149:1190-1204 (Pubitemid 351397966)
13. Matsuzaki S, Canis M, Pouly JL, Déchelotte PJ, Mage G 2006 Analysis of aromatase and 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Fertil Steril 85:308-313 (Pubitemid 43170901)
14. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H 1997 Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 57:514-519 (Pubitemid 27349909)
15. Fang Z, Yang S, Gurates B, Tamura M, Simpson E, Evans D, Bulun SE 2002 Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab 87:3460-3466 (Pubitemid 34816404)
16. Husen B, Huhtinen K, Saloniemi T, Messinger J, Thole HH, Poutanen M 2006 Human hydroxysteroid (17-β) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts. Endocrinology 147:5333-5339 (Pubitemid 44790588)
17. Messinger J, Hirvelä L, Husen B, Kangas L, Koskimies P, Pentikäinen O, Saarenketo P, Thole H 2006 New inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Mol Cell Endocrinol 248:192-198
18. Marchais-Oberwinkler S, Henn C, Möller G, Klein T, Negri M, Oster A, Spadaro A, Werth R, Wetzel M, Xu K, Frotscher M, Hartmann RW, Adamski J 2011 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development. J Steroid BiochemMol Biol 125:66-82
19. Ferrero S, Venturini PL, Ragni N, Camerini G, Remorgida V 2009 Pharmacological treatment of endometriosis: experience with aromatase inhibitors. Drugs 69:943-952
20. Bulun SE, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, Johns A, Putman M, Sasano H 1999 Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer 6:293-301 (Pubitemid 29260065)
21. Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, Setälä M, Härkki P, Jalkanen J, Fraser J, Mäkinen J, Auranen A, Poutanen M, Perheentupa A 2009 Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer 100:1315-1319
22. Harwood DT, Handelsman DJ 2009 Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta 409:78-84
23. McNamara KM, Harwood DT, Simanainen U, Walters KA, Jimenez M, Handelsman DJ 2010 Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol 121:611-618
24. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
25. Hiissa J, Elo LL, Huhtinen K, Perheentupa A, Poutanen M, Aittokallio T 2009 Resampling reveals sample-level differential expression in clinical genome-wide studies. OMICS 13:381-396
26. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B, Bulun SE 1998 Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. J Clin Endocrinol Metab 83:4474-4480 (Pubitemid 29100154)
27. Cheng YH, Yin P, Xue Q, Yilmaz B, Dawson MI, Bulun SE 2008 Retinoic acid (RA) regulates 17β-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J Clin Endocrinol Metab 93:1915-1923 (Pubitemid 351656538)
28. Huang XF, Luu-The V 2000 Molecular characterization of a first human 3(α->β)-hydroxysteroid epimerase. J Biol Chem 275:29452-29457 (Pubitemid 32043820)
29. Chetyrkin SV, Hu J, Gough WH, Dumaual N, Kedishvili NY 2001 Further characterization of human microsomal 3α-hydroxysteroid dehydrogenase. Arch Biochem Biophys 386:1-10 (Pubitemid 32980170)
30. Muthusamy S, Andersson S, Kim HJ, Butler R, Waage L, Bergerheim U, Gustafsson JÅ 2011 Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer. Proc Natl Acad Sci USA 108:20090-20094
31. Smuc T, Pucelj MR, Sinkovec J, Husen B, Thole H, Lanisnik Rizner T 2007 Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol 23:105-111 (Pubitemid 46481023)
32. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J, Bulun SE 2007 Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 77:681-687 (Pubitemid 47494383)
33. Fujimoto J, Hirose R, Sakaguchi H, Tamaya T 1999 Expression of oestrogen receptor-α and -β in ovarian endometriomata. Mol Hum Reprod 5:742-747 (Pubitemid 29366872)